Drug class
Antimuscarinic antiparkinsonian agent; central muscarinic acetylcholine receptor antagonist
Mechanism of action
Blocks central muscarinic acetylcholine receptors, restoring dopaminergic-cholinergic balance in basal ganglia circuits and reducing tremor and rigidity.
General use cases
- Treatment of parkinsonian symptoms, including drug-induced extrapyramidal symptoms, in countries where procyclidine remains authorised; not all movement disorders respond and anticholinergic adverse effects limit use
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
